Our Lab focuses on the development of psychedelic derived pharmacothérapies for the treatment of major psychiatric disorders such as depression, bipolar disorder, PTSD and schizophrenia.
Selected Awards
Grants from
Israel Science Foundation
Israel Ministry of Science and Innovation
European Union